IL6 and Crouzon syndrome-acanthosis nigricans syndrome: We confirmed that CAN significantly reduced the inflammatory factors IL-6 and TNF-α in the SASP, and these results were consistent with a previous laboratory study in which we reported that CAN has anti-inflammatory activity and can lower intracellular inflammatory factor levels [13].